JP MORGAN/PUT/PFIZER INC/26/0.1/17.01.25 Stock

Warrant

DE000JL4LUL9

Market Closed - Börse Stuttgart 04:54:47 2024-07-03 EDT
0.12 EUR +9.09% Intraday chart for JP MORGAN/PUT/PFIZER INC/26/0.1/17.01.25
1 month+20.00%
3 months-29.41%
Date Price Change
24-07-03 0.12 +9.09%
24-07-02 0.11 0.00%
24-07-01 0.11 -8.33%
24-06-28 0.12 -7.69%
24-06-27 0.13 +30.00%

Delayed Quote Börse Stuttgart

Last update July 03, 2024 at 04:54 am

More quotes

Static data

Product typeWarrants
Buy / SellPUT
Underlying PFIZER, INC.
Issuer J.P. Morgan
WKN JL4LUL
ISINDE000JL4LUL9
Date issued 2023-05-19
Strike 26 $
Maturity 2025-01-17 (198 Days)
Parity 10 : 1
Emission price 0.1
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 0.31
Lowest since issue 0.077
Delta-0.33x
Omega 6.579
Premium11.2x
Gearing19.76x
Moneyness 0.9386
Difference Strike -1.7 $
Difference Strike %-6.54%
Spread 0.02
Spread %14.29%
Theoretical value 0.1300
Implied Volatility 27.61 %
Total Loss Probability 58.20 %
Intrinsic value 0.000000
Present value 0.1300
Break even 24.60 €
Theta-0x
Vega0.01x
Rho-0x

Company Profile

Pfizer, Inc. is the world's leading pharmaceutical group. Net sales break down by family of products as follows: - primary care products (72.8%): medicines used in internal medicine, vaccines, medicines for the prevention and treatment of Covid-19, antivirals, mRNA-based products, etc.; - specialty care products (13.8%): medicines used in immunology, in hospitals and for the treatment of rare diseases, anti-inflammatory medicines, etc.; - oncology products (12.1%); - other (1.3%). At the end of 2022, the group had more than 35 manufacturing sites worldwide. Net sales are distributed geographically as follows: the United States (42.3%), Europe (21.9%) and other (35.8%).
Sector
-
More about the company

Ratings for Pfizer, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Pfizer, Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
24
Last Close Price
27.7 USD
Average target price
31.92 USD
Spread / Average Target
+15.22%
Consensus